Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TYMS | P04818 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21886355 | 0.92 | KDM4E (0.41) | KDM4EMAPK1ATMMEN1USP2 | |
| SCHEMBL24254092 | 0.90 | TNF (0.34) | KDM4EMAPK1ATM | |
| SCHEMBL14010649 | 0.90 | CRHBP (0.38) | KDM4EMAPK1ATMMEN1USP2 | |
| SCHEMBL18021777 | 0.88 | KDM4E (0.44) | KDM4EMAPK1ATMMEN1USP2 | |
| SCHEMBL27351570 | 0.88 | KDM4E (0.39) | KDM4EMAPK1ATMMEN1KMT2A | |
| SCHEMBL27351568 | 0.88 | KDM4E (0.39) | KDM4EMAPK1ATMMEN1KMT2A | |
| SCHEMBL18021769 | 0.87 | KDM4E (0.43) | KDM4EMAPK1ATMMEN1USP2 | |
| SCHEMBL17999924 | 0.86 | KDM4E (0.35) | KDM4EMAPK1ATM | |
| SCHEMBL18021828 | 0.86 | KDM4E (0.44) | KDM4EMAPK1ATMMEN1KMT2A | |
| SCHEMBL18021823 | 0.85 | KDM4E (0.43) | KDM4EMAPK1ATMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220052272-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220052272-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TMEM109, OR10J3, LEF1 | KDM4E 1347/4885MAPK1 482/4885ATM 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.